This difference could be related to impaired homologous recombination as the 18067T allele variant of XRCC3 was more frequent in 134 thyroid cancer patients than in 166 healthy patients in another study (Sturgis et al, 2005). The gene discussed is XRCC3; the disease is thyroid gland carcinoma.